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Abstract 
Review on Cytochrome B5 Type A, with data on 
DNA/RNA, on the protein encoded and the diseases 
in which the gene has been implicated. 
Identity 
Other names: MCB5, CYB5 
HGNC (Hugo): CYB5A 
Location: 18q22.3 
Local order 
Based on MapViewer, genes flanking are: 
-FBX015 (F-box protein 15); 18q22.3 
-TIMM21 (Translocase of Inner Mitochondrial 
Membrane 21 Homolog (yeast); 18q22.3 
-CYB5A; 18q22.3 
-C18orf63 (Chromosome 18 Open Reading Frame 
63); 18q22.3 
-FAUP1 (FBR-MuSV-Associated Ubiquitously 
Expressed (fox derived) Pseudogene 1; 18q22.3 
DNA/RNA 
Description 
The CYB5A gene is situated on chromosome 18, 
starting from 74250847 and ending at 74292016 bp. 
The gene encodes a membrane-bound cytochrome 
protein. 
Transcription 
For this gene, seven alternatively spliced transcript 
variants have been identified (CYB5A-001, -002, -
003, -004, -005, -006 and -007). Variants -001, -002, 
-005 and -006 are transcripts encoding for a protein 
containing 134, 98 and 124, respectively. The 
remaining variants do not code for a protein product: 
Variant -007 is a processed transcript containing 4 
exons, whereas variants -003 and -004 have retained 
introns. 
Figure 1. Localization of CYB5A on chromosome 18, q22.3. CYB5A starts from 74250847 and ends at 74292016 bp. 
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Protein 
Description 
CYB5A belongs to the cytochrome b5 family of 
electron transport proteins found in yeasts, plants 
and animals. As a product of alternative splicing, the 
CYB5A gene encodes three distinct protein 
isoforms; the 134 amino acid membrane-bound form 
with a predicted molecular weight of 15,3 kDa, the 
98 amino acid cytoplasmic form with 11,3 kDa and 
a 98 residues isoform from which experimental 
confirmation is lacking. The membrane-bound 
protein is composed of a single polypeptide chain 
folded into two domains which are structurally 
independent. A non-polar fragment, able to anchor 
the polypeptide chain to the membrane and a polar, 
heme-binding fragment with catalytic activity. 
Expression 
The expression of cytochrome B type A seems to be 
highly regulated in some mammals.  In rats with 
hypothyroidism, for instance, increased CYB5A 
levels have been found.  Furthermore, a compound 
called propylthiouracil, which was used to treat 
hyperthyroidism triggered a similar effect, leading to 
a 50% increase in cytochrome B type A levels. 
Huang and colleagues studied the transcriptional 
regulation of human adrenal NClH295A cells and 
found that it was regulated by Sp3, SF1, GATA-6 
and NF-1C, four of the five factors which also exert 
regulating effects on P450c17. 
Function 
Cytochrome B5 Type A is a hemoprotein which 
serves as an electron carrier in various biochemical 
reactions. Its most important function is the 
NADPH-dependent reduction of methemoglobin to 
ferrous hemoglobin, a factor required for stearyl-
CoA-desaturase activity. Morevoer, cytochrome B5 
Type A participates in fatty acid desaturation, sterol 
metabolism and cytochrome P450-catalyzed 
reactions. 
Homology 
The CYB5A gene is conserved in Rhesus monkey, 
chimpanzee, cow, dog, rat, mouse, chicken, frog, 
mosquito, fruit fly, C. elegans, rice and A. thaliana. 
Mutations 
Germinal 
A homozygous splice site mutation in the CYB5A 
gene in a patient with type IV hereditary 
methemoglobinemia was identified by Steggles and 
colleagues. The group isolated mRNA from 
reticulocytes and leukocytes from the patient and 
analyzed the CYB5A cDNA sequences by DNA 
sequencing. They found a 16-bp deletion in the 
cDNA which led to a new in-frame termination 
codon, thereby producing a truncated protein of 45 
amino acid residues. Genomic DNA analysis 
revealed an AG-to-GC modification in the consensus 
3' splicing junction of intron 1. The presence of this 
modification renders the splicing machinery to make 
use of the nearest AG in exon 2 as an alternative 
splice site, resulting in a 16-bp deletion in the 
mRNA. 
Somatic 
Additionally, a survey in the COSMIC mutation 
database (accession date: 6 November 6, 2015) 
revealed a total of 24 mutations present in different 
human tumors.  
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Table 1. CYB5A mutations present in distinct types of 
tumors.  The table includes the DNA modification (CDS 
Mutation), protein modification (AA Mutation), tissue and 
type of mutation (c.369C>T; c.45G>A; c.366C>T; 
c.138T>C: Substitution-coding silent, c.339G>A: 
Substitution-nonsense, c.245 246GG>TT: Complex, other: 
Substitution-missense). 
Implicated in 
Breast cancer 
The effects of cytochrome b5 on breast cancer 
remain unclear. A proteomic approach addressed by 
Neubauer and collaborators found differences in the 
cytochrome b5 levels of sensitive to tamoxifen 
(ER+/PR+) and less sensitive (ER+/PR-) mammary 
tumor specimens. The ER+/PR+ samples exhibited 
decreased levels of cytochrome b5 and this lead the 
group to suggest that the differential susceptibility 
against tamoxifen might, in part be explained, as a 
result of aberrant cytochrome b5-dependent 
metabolism. 
Pancreatic cancer 
CYB5A has been recently identified as a prognostic 
factor for Pancreatic Cancer Adenocarcinoma 
(PDAC). Giovannetti and collaborators performed 
comparative genomic hybridization studies in 
resected patients and found a significant correlation 
between decreased survival and the loss of the 
cytoband 18q22.3, where CYB5A is located. 
Analysis of mRNA and protein levels of other 
cohorts revealed the prognostic value of CYB5A: 
decreased CYB5A expression levels were associated 
with shorter survival. In vivo orthotopic models with 
patient-derived CYB5A+ cells showed a significant 
reduction in tumor size coupled with increased 
survival compared to the controls. Interestingly, 
additional gain- and loss-of function studies 
performed by the group revealed a novel role of 
CYB5A, namely, autophagy induction. 
Hepatocellular carcinoma (HCC) 
Lee and collaborators addressed a proteomic 
approach in order to identify novel biomarkers in 
resected tumor and adjacent non-malignant tissue 
samples of 80 HCC patients. This study revealed that 
CYB5A significantly correlated with serum AFP, a 
biomarker commonly used for HCC surveillance. 
Moreover they suggested that its decreased levels 
might be a result of the disruption of the membrane-
bound polysome attachment, which is required for 
cytochrome b5 type A synthesis. 
Lung squamous cell carcinoma 
Sriram and colleagues analyzed 62 primary lung 
SCCs (28 with recurrence and 34 with no evidence 
of recurrence) using a whole-genome aCGH 
microarray to identify genomic copy number 
alterations specific to tumors. They identified 
CYB5A among prognostic genes that had lower 
copy number in the lung SCC of patients who 
recurred (Sriram et al., 2012). Moreover, they 
demonstrated association of the reduced copy 
number and mRNA expression of SOCS6 with 
disease recurrence in SCC patients. 
Ovarian cancer 
Cortesi et al., performed a comparative proteomic 
study on biopsies from six consecutive patients with 
endometrioid or serous ovarian carcinoma who had 
not been previously treated with chemotherapy prior 
to surgical resection, in order to recognize potential 
biomarkers.  
They identified CYB5A among the proteins 
separated by 2-DE electrophoresis and detected by 
MS analysis. 
Colorectal tumors 
Agostini and collaborators evaluated the value of ten 
markers including CYB5A (D18S58) in 44 CRC 
patients, who underwent surgery using a multiplex 
PCR assay for a rapid and proper classification of 
tumor microsatellite instability (MSI)-H, MSI-L and 
MSS. They revealed that a complete panel of these 
markers could allow the accurate evaluation of 
tumor MSI status in CRC patients, supporting further 
investigations on the prognostic value of CYB5A 
and other markers in management of CRC patients. 
Gastric Cancer 
Nair and colleagues carried out gene expression 
analysis in Singapore and UK Gastric cancer 
datasets using GeneSpring. This study showed the 
upregulation of CYB5A in the Singapore's 
Population (Nair et al., 2014). 
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Rheumatoid arthritis (RA) 
RA is characterized by decreased androgens levels 
and CYB5A acts as a cofactor of one of the two 
enzymes responsible for de novo androgens 
synthesis, cytochrome P450 17A1 (17,20-lyase). For 
this reason, Stark and collaborators analyzed the 
presence of Single Nucleotide Polymorphisms 
(SNPs) in the CYB5A gene in two published RA 
Genome Wide Association Study (GWAS) datasets. 
Subsequently, cytochrome b5 expression analyses as 
well as androgen production after steroid conversion 
were evaluated in candidate SNPs from a RA case-
control study. Among the most important findings 
was the identification of a SNP in CYB5A, 
designated as rs1790834, which was associated to 
decreased risk of RA. The group suggested that 
rs1790834 might exert its protective effects by 
increasing the capacity of androgen synthesis. 
Type 2 diabetes and adiposity 
Huang and colleagues performed whole exome 
sequencing in order to identify potential functional 
coding variants affecting metabolic processes 
associated with increased risk of type 2 diabetes.  
Their analyses revealed a SNP in CYB5A, 
designated as rs7238987, which was significantly 
associated with pre-diabetic traits such as Percentage 
Body Fat (PFAT) and Body Mass Index (BMI). All 
together, the group identified a potential new locus 
for adiposity and higher risk of type 2 diabetes. 
Nevertheless, functional studies validating these 
results are still lacking. 
Cushing' Syndrome 
The effects of cytochrome b5 on cytochrome P450 
17A1 have been shown by distinct research groups. 
Since Cushing's syndrome is characterized by 
abnormalities in the production of cortisol and 
adrenal androgens, the expression levels and activity 
of cytochrome b5 in this condition have also been 
evaluated. Sakai and colleagues performed in vitro 
biochemical assays on adrenocortical adenoma 
tissue from Cushin's syndrome patients and found 
high levels of cytochrome b5, which correlated with 
higher 17,20-lyase activity. Moreover, an 
immunohistochemical study performed by Yanase 
and collaborators revealed high cytochrome b5 
levels in all adrenocortical layers in adrenal glands, 
with a particularly intense immunoreactivity in the 
zona reticularis, providing evidence for the 
functional association between cytochrome b5 type 
A and the production of adrenal androgens. 
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